News AI giant Anthropic buys Coefficient Bio for $400m Anthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio.
News Lilly puts up to $2.75bn into Insilico alliance Insilico has once again added to its roster of big pharma partners, signing a deal with Eli Lilly that includes a $115m upfront payment.
News AI in drug discovery and development: news watch Recent developments in the biopharma AI world include a big financing for Verily, and updates from Zealand, Latent Labs, Insilico, and BMS/insitro.
News Basecamp lifts veil on Trillion Gene Atlas genomics push Basecamp Research's Trillion Gene Atlas will bring together genomic data from millions of species to guide AI-powered design of new medicines.
News Roche accelerates AI adoption with NVIDIA deal Roche has ramped up its investment in NVIDIA's AI chips, launching a hybrid-cloud AI factory that it believes is the largest in the pharma industry.
News NVIDIA sinks $2bn into AI cloud provider Nebius NVIDIA has agreed a $2 billion partnership with AI cloud provider Nebius to ramp up infrastructure as demand soars in the life sciences.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
